Scholarlink

<p>This study evaluated patient satisfaction and expectation levels in individuals with chronic low back pain (LBP), myofascial pain syndrome (MPS), and knee osteoarthritis (KOA) who received mud pack therapy (MPT). It also investigated the relationship between these conditions and pain levels, global assessment results, and side effects.&#xa0;We assessed 250 patients (n = 74 for LBP, n = 75 for MPS, n = 101 for KOA) who underwent twelve sessions of MPT at 43 °C, lasting 30 min each. Patients continued their routine care and completed surveys on satisfaction and expectations, as well as measures of pain (VAS-pain), global assessment (VAS-PGA), and acceptable symptom state (PASS).&#xa0;Satisfaction levels were reported as “satisfied” or “definitely satisfied” by 93.1% to 96% of patients. Expectations were met by 86.7% to 89.2% of patients. Both VAS-pain and VAS-PGA showed statistically significant improvements after treatment (p &lt; 0.001), though there were no differences between groups (p = 0.794 for VAS-pain, p = 0.234 for VAS-PGA). The PASS evaluation showed no significant group differences (p = 0.274). No serious side effects were reported, except for mild, short-term increases in pain.&#xa0;MPT is an effective treatment providing significant pain relief for LBP, MPS, and KOA patients, with high satisfaction and expectation fulfillment among participants.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The evaluation of medical mud pack treatment from the patient’s perspective in different musculoskeletal disorders- A prospective study

  • 期刊论文

  • 发表日期：

    2025年10月14日

查看全文
  • Fatih Karaarslan,
  • Fulya Demircioğlu Güneri,
  • Hülya Özen,
  • Ersin Odabaşı

摘要

This study evaluated patient satisfaction and expectation levels in individuals with chronic low back pain (LBP), myofascial pain syndrome (MPS), and knee osteoarthritis (KOA) who received mud pack therapy (MPT). It also investigated the relationship between these conditions and pain levels, global assessment results, and side effects. We assessed 250 patients (n = 74 for LBP, n = 75 for MPS, n = 101 for KOA) who underwent twelve sessions of MPT at 43 °C, lasting 30 min each. Patients continued their routine care and completed surveys on satisfaction and expectations, as well as measures of pain (VAS-pain), global assessment (VAS-PGA), and acceptable symptom state (PASS). Satisfaction levels were reported as “satisfied” or “definitely satisfied” by 93.1% to 96% of patients. Expectations were met by 86.7% to 89.2% of patients. Both VAS-pain and VAS-PGA showed statistically significant improvements after treatment (p < 0.001), though there were no differences between groups (p = 0.794 for VAS-pain, p = 0.234 for VAS-PGA). The PASS evaluation showed no significant group differences (p = 0.274). No serious side effects were reported, except for mild, short-term increases in pain. MPT is an effective treatment providing significant pain relief for LBP, MPS, and KOA patients, with high satisfaction and expectation fulfillment among participants.